Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Transdermal Drug Delivery Systems Market Growth (Status and Outlook) 2022-2028

  • LP 4725182
  • 114 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transdermal Drug Delivery Systems will have significant change from previous year. According to our (LP Information) latest study, the global Transdermal Drug Delivery Systems market size is USD million in 2022 from USD 14730 million in 2021, with a change of % between 2021 and 2022. The global Transdermal Drug Delivery Systems market size will reach USD 35780 million in 2028, growing at a CAGR of 13.5% over the analysis period.

The United States Transdermal Drug Delivery Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transdermal Drug Delivery Systems market, reaching US$ million by the year 2028. As for the Europe Transdermal Drug Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transdermal Drug Delivery Systems players cover Hisamitsu, Mylan, GSK, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Delivery Systems market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

OTC

Rx

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Hisamitsu

Mylan

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

Teikoku Seiyaku

Bayer

Novartis

Teve (Actavis)

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transdermal Drug Delivery Systems Market Size 2017-2028

2.1.2 Transdermal Drug Delivery Systems Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Transdermal Drug Delivery Systems Segment by Type

2.2.1 Fentanyl

2.2.2 Nitroglycerin

2.2.3 Estradiol

2.2.4 Nicotine

2.2.5 Other

2.3 Transdermal Drug Delivery Systems Market Size by Type

2.3.1 Transdermal Drug Delivery Systems Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2022)

2.4 Transdermal Drug Delivery Systems Segment by Application

2.4.1 OTC

2.4.2 Rx

2.5 Transdermal Drug Delivery Systems Market Size by Application

2.5.1 Transdermal Drug Delivery Systems Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2022)

3 Transdermal Drug Delivery Systems Market Size by Player

3.1 Transdermal Drug Delivery Systems Market Size Market Share by Players

3.1.1 Global Transdermal Drug Delivery Systems Revenue by Players (2020-2022)

3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2020-2022)

3.2 Global Transdermal Drug Delivery Systems Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Transdermal Drug Delivery Systems by Regions

4.1 Transdermal Drug Delivery Systems Market Size by Regions (2017-2022)

4.2 Americas Transdermal Drug Delivery Systems Market Size Growth (2017-2022)

4.3 APAC Transdermal Drug Delivery Systems Market Size Growth (2017-2022)

4.4 Europe Transdermal Drug Delivery Systems Market Size Growth (2017-2022)

4.5 Middle East & Africa Transdermal Drug Delivery Systems Market Size Growth (2017-2022)

5 Americas

5.1 Americas Transdermal Drug Delivery Systems Market Size by Country (2017-2022)

5.2 Americas Transdermal Drug Delivery Systems Market Size by Type (2017-2022)

5.3 Americas Transdermal Drug Delivery Systems Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transdermal Drug Delivery Systems Market Size by Region (2017-2022)

6.2 APAC Transdermal Drug Delivery Systems Market Size by Type (2017-2022)

6.3 APAC Transdermal Drug Delivery Systems Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Transdermal Drug Delivery Systems by Country (2017-2022)

7.2 Europe Transdermal Drug Delivery Systems Market Size by Type (2017-2022)

7.3 Europe Transdermal Drug Delivery Systems Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transdermal Drug Delivery Systems by Region (2017-2022)

8.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2017-2022)

8.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Transdermal Drug Delivery Systems Market Forecast

10.1 Global Transdermal Drug Delivery Systems Forecast by Regions (2023-2028)

10.1.1 Global Transdermal Drug Delivery Systems Forecast by Regions (2023-2028)

10.1.2 Americas Transdermal Drug Delivery Systems Forecast

10.1.3 APAC Transdermal Drug Delivery Systems Forecast

10.1.4 Europe Transdermal Drug Delivery Systems Forecast

10.1.5 Middle East & Africa Transdermal Drug Delivery Systems Forecast

10.2 Americas Transdermal Drug Delivery Systems Forecast by Country (2023-2028)

10.2.1 United States Transdermal Drug Delivery Systems Market Forecast

10.2.2 Canada Transdermal Drug Delivery Systems Market Forecast

10.2.3 Mexico Transdermal Drug Delivery Systems Market Forecast

10.2.4 Brazil Transdermal Drug Delivery Systems Market Forecast

10.3 APAC Transdermal Drug Delivery Systems Forecast by Region (2023-2028)

10.3.1 China Transdermal Drug Delivery Systems Market Forecast

10.3.2 Japan Transdermal Drug Delivery Systems Market Forecast

10.3.3 Korea Transdermal Drug Delivery Systems Market Forecast

10.3.4 Southeast Asia Transdermal Drug Delivery Systems Market Forecast

10.3.5 India Transdermal Drug Delivery Systems Market Forecast

10.3.6 Australia Transdermal Drug Delivery Systems Market Forecast

10.4 Europe Transdermal Drug Delivery Systems Forecast by Country (2023-2028)

10.4.1 Germany Transdermal Drug Delivery Systems Market Forecast

10.4.2 France Transdermal Drug Delivery Systems Market Forecast

10.4.3 UK Transdermal Drug Delivery Systems Market Forecast

10.4.4 Italy Transdermal Drug Delivery Systems Market Forecast

10.4.5 Russia Transdermal Drug Delivery Systems Market Forecast

10.5 Middle East & Africa Transdermal Drug Delivery Systems Forecast by Region (2023-2028)

10.5.1 Egypt Transdermal Drug Delivery Systems Market Forecast

10.5.2 South Africa Transdermal Drug Delivery Systems Market Forecast

10.5.3 Israel Transdermal Drug Delivery Systems Market Forecast

10.5.4 Turkey Transdermal Drug Delivery Systems Market Forecast

10.5.5 GCC Countries Transdermal Drug Delivery Systems Market Forecast

10.6 Global Transdermal Drug Delivery Systems Forecast by Type (2023-2028)

10.7 Global Transdermal Drug Delivery Systems Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Hisamitsu

11.1.1 Hisamitsu Company Information

11.1.2 Hisamitsu Transdermal Drug Delivery Systems Product Offered

11.1.3 Hisamitsu Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Hisamitsu Main Business Overview

11.1.5 Hisamitsu Latest Developments

11.2 Mylan

11.2.1 Mylan Company Information

11.2.2 Mylan Transdermal Drug Delivery Systems Product Offered

11.2.3 Mylan Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Mylan Main Business Overview

11.2.5 Mylan Latest Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Transdermal Drug Delivery Systems Product Offered

11.3.3 GSK Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 GSK Main Business Overview

11.3.5 GSK Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Transdermal Drug Delivery Systems Product Offered

11.4.3 Novartis Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Teve (Actavis)

11.5.1 Teve (Actavis) Company Information

11.5.2 Teve (Actavis) Transdermal Drug Delivery Systems Product Offered

11.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Teve (Actavis) Main Business Overview

11.5.5 Teve (Actavis) Latest Developments

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Information

11.6.2 Johnson & Johnson Transdermal Drug Delivery Systems Product Offered

11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Johnson & Johnson Main Business Overview

11.6.5 Johnson & Johnson Latest Developments

11.7 Lohmann

11.7.1 Lohmann Company Information

11.7.2 Lohmann Transdermal Drug Delivery Systems Product Offered

11.7.3 Lohmann Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Lohmann Main Business Overview

11.7.5 Lohmann Latest Developments

11.8 Teikoku Seiyaku

11.8.1 Teikoku Seiyaku Company Information

11.8.2 Teikoku Seiyaku Transdermal Drug Delivery Systems Product Offered

11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Teikoku Seiyaku Main Business Overview

11.8.5 Teikoku Seiyaku Latest Developments

11.9 Bayer

11.9.1 Bayer Company Information

11.9.2 Bayer Transdermal Drug Delivery Systems Product Offered

11.9.3 Bayer Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Bayer Main Business Overview

11.9.5 Bayer Latest Developments

11.10 Novartis

11.10.1 Novartis Company Information

11.10.2 Novartis Transdermal Drug Delivery Systems Product Offered

11.10.3 Novartis Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Novartis Main Business Overview

11.10.5 Novartis Latest Developments

11. Teve (Actavis)

11.11.1 Teve (Actavis) Company Information

11.11.2 Teve (Actavis) Transdermal Drug Delivery Systems Product Offered

11.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Teve (Actavis) Main Business Overview

11.11.5 Teve (Actavis) Latest Developments

11.12 Qizheng

11.12.1 Qizheng Company Information

11.12.2 Qizheng Transdermal Drug Delivery Systems Product Offered

11.12.3 Qizheng Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Qizheng Main Business Overview

11.12.5 Qizheng Latest Developments

11.13 Endo

11.13.1 Endo Company Information

11.13.2 Endo Transdermal Drug Delivery Systems Product Offered

11.13.3 Endo Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Endo Main Business Overview

11.13.5 Endo Latest Developments

11.14 Huarun 999

11.14.1 Huarun 999 Company Information

11.14.2 Huarun 999 Transdermal Drug Delivery Systems Product Offered

11.14.3 Huarun 999 Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Huarun 999 Main Business Overview

11.14.5 Huarun 999 Latest Developments

11.15 Haw Par

11.15.1 Haw Par Company Information

11.15.2 Haw Par Transdermal Drug Delivery Systems Product Offered

11.15.3 Haw Par Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Haw Par Main Business Overview

11.15.5 Haw Par Latest Developments

11.16 Nichiban

11.16.1 Nichiban Company Information

11.16.2 Nichiban Transdermal Drug Delivery Systems Product Offered

11.16.3 Nichiban Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Nichiban Main Business Overview

11.16.5 Nichiban Latest Developments

11.17 Mentholatum

11.17.1 Mentholatum Company Information

11.17.2 Mentholatum Transdermal Drug Delivery Systems Product Offered

11.17.3 Mentholatum Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Mentholatum Main Business Overview

11.17.5 Mentholatum Latest Developments

11.18 Laboratoires Genevrier

11.18.1 Laboratoires Genevrier Company Information

11.18.2 Laboratoires Genevrier Transdermal Drug Delivery Systems Product Offered

11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Laboratoires Genevrier Main Business Overview

11.18.5 Laboratoires Genevrier Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Transdermal Drug Delivery Systems Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Fentanyl

Table 3. Major Players of Nitroglycerin

Table 4. Major Players of Estradiol

Table 5. Major Players of Nicotine

Table 6. Major Players of Other

Table 7. Transdermal Drug Delivery Systems Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2022)

Table 10. Transdermal Drug Delivery Systems Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2022)

Table 13. Global Transdermal Drug Delivery Systems Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Transdermal Drug Delivery Systems Revenue Market Share by Player (2020-2022)

Table 15. Transdermal Drug Delivery Systems Key Players Head office and Products Offered

Table 16. Transdermal Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Transdermal Drug Delivery Systems Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Transdermal Drug Delivery Systems Market Size Market Share by Regions (2017-2022)

Table 21. Americas Transdermal Drug Delivery Systems Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Transdermal Drug Delivery Systems Market Size Market Share by Country (2017-2022)

Table 23. Americas Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2022)

Table 25. Americas Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2022)

Table 27. APAC Transdermal Drug Delivery Systems Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Transdermal Drug Delivery Systems Market Size Market Share by Region (2017-2022)

Table 29. APAC Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2022)

Table 31. APAC Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2022)

Table 33. Europe Transdermal Drug Delivery Systems Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Transdermal Drug Delivery Systems Market Size Market Share by Country (2017-2022)

Table 35. Europe Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2022)

Table 37. Europe Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Transdermal Drug Delivery Systems Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Transdermal Drug Delivery Systems Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Transdermal Drug Delivery Systems Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Transdermal Drug Delivery Systems

Table 46. Key Market Challenges & Risks of Transdermal Drug Delivery Systems

Table 47. Key Industry Trends of Transdermal Drug Delivery Systems

Table 48. Global Transdermal Drug Delivery Systems Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Transdermal Drug Delivery Systems Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Transdermal Drug Delivery Systems Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Transdermal Drug Delivery Systems Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Transdermal Drug Delivery Systems Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Transdermal Drug Delivery Systems Market Size Market Share Forecast by Application (2023-2028)

Table 54. Hisamitsu Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 55. Hisamitsu Transdermal Drug Delivery Systems Product Offered

Table 56. Hisamitsu Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Hisamitsu Main Business

Table 58. Hisamitsu Latest Developments

Table 59. Mylan Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 60. Mylan Transdermal Drug Delivery Systems Product Offered

Table 61. Mylan Main Business

Table 62. Mylan Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Mylan Latest Developments

Table 64. GSK Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 65. GSK Transdermal Drug Delivery Systems Product Offered

Table 66. GSK Main Business

Table 67. GSK Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. GSK Latest Developments

Table 69. Novartis Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 70. Novartis Transdermal Drug Delivery Systems Product Offered

Table 71. Novartis Main Business

Table 72. Novartis Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Novartis Latest Developments

Table 74. Teve (Actavis) Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 75. Teve (Actavis) Transdermal Drug Delivery Systems Product Offered

Table 76. Teve (Actavis) Main Business

Table 77. Teve (Actavis) Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Teve (Actavis) Latest Developments

Table 79. Johnson & Johnson Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 80. Johnson & Johnson Transdermal Drug Delivery Systems Product Offered

Table 81. Johnson & Johnson Main Business

Table 82. Johnson & Johnson Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Johnson & Johnson Latest Developments

Table 84. Lohmann Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 85. Lohmann Transdermal Drug Delivery Systems Product Offered

Table 86. Lohmann Main Business

Table 87. Lohmann Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Lohmann Latest Developments

Table 89. Teikoku Seiyaku Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 90. Teikoku Seiyaku Transdermal Drug Delivery Systems Product Offered

Table 91. Teikoku Seiyaku Main Business

Table 92. Teikoku Seiyaku Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Teikoku Seiyaku Latest Developments

Table 94. Bayer Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 95. Bayer Transdermal Drug Delivery Systems Product Offered

Table 96. Bayer Main Business

Table 97. Bayer Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Bayer Latest Developments

Table 99. Novartis Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 100. Novartis Transdermal Drug Delivery Systems Product Offered

Table 101. Novartis Main Business

Table 102. Novartis Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Novartis Latest Developments

Table 104. Teve (Actavis) Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 105. Teve (Actavis) Transdermal Drug Delivery Systems Product Offered

Table 106. Teve (Actavis) Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Teve (Actavis) Main Business

Table 108. Teve (Actavis) Latest Developments

Table 109. Qizheng Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 110. Qizheng Transdermal Drug Delivery Systems Product Offered

Table 111. Qizheng Main Business

Table 112. Qizheng Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Qizheng Latest Developments

Table 114. Endo Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 115. Endo Transdermal Drug Delivery Systems Product Offered

Table 116. Endo Main Business

Table 117. Endo Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Endo Latest Developments

Table 119. Huarun 999 Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 120. Huarun 999 Transdermal Drug Delivery Systems Product Offered

Table 121. Huarun 999 Main Business

Table 122. Huarun 999 Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Huarun 999 Latest Developments

Table 124. Haw Par Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 125. Haw Par Transdermal Drug Delivery Systems Product Offered

Table 126. Haw Par Main Business

Table 127. Haw Par Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Haw Par Latest Developments

Table 129. Nichiban Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 130. Nichiban Transdermal Drug Delivery Systems Product Offered

Table 131. Nichiban Main Business

Table 132. Nichiban Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Nichiban Latest Developments

Table 134. Mentholatum Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 135. Mentholatum Transdermal Drug Delivery Systems Product Offered

Table 136. Mentholatum Main Business

Table 137. Mentholatum Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Mentholatum Latest Developments

Table 139. Laboratoires Genevrier Details, Company Type, Transdermal Drug Delivery Systems Area Served and Its Competitors

Table 140. Laboratoires Genevrier Transdermal Drug Delivery Systems Product Offered

Table 141. Laboratoires Genevrier Main Business

Table 142. Laboratoires Genevrier Transdermal Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. Laboratoires Genevrier Latest Developments

List of Figures

Figure 1. Transdermal Drug Delivery Systems Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Transdermal Drug Delivery Systems Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Transdermal Drug Delivery Systems Market Size Market Share by Type in 2021

Figure 7. Transdermal Drug Delivery Systems in OTC

Figure 8. Global Transdermal Drug Delivery Systems Market: OTC (2017-2022) & ($ Millions)

Figure 9. Transdermal Drug Delivery Systems in Rx

Figure 10. Global Transdermal Drug Delivery Systems Market: Rx (2017-2022) & ($ Millions)

Figure 11. Global Transdermal Drug Delivery Systems Market Size Market Share by Application in 2021

Figure 12. Global Transdermal Drug Delivery Systems Revenue Market Share by Player in 2021

Figure 13. Global Transdermal Drug Delivery Systems Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Transdermal Drug Delivery Systems Market Size 2017-2022 ($ Millions)

Figure 15. APAC Transdermal Drug Delivery Systems Market Size 2017-2022 ($ Millions)

Figure 16. Europe Transdermal Drug Delivery Systems Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Transdermal Drug Delivery Systems Market Size 2017-2022 ($ Millions)

Figure 18. Americas Transdermal Drug Delivery Systems Value Market Share by Country in 2021

Figure 19. Americas Transdermal Drug Delivery Systems Consumption Market Share by Type in 2021

Figure 20. Americas Transdermal Drug Delivery Systems Market Size Market Share by Application in 2021

Figure 21. United States Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Transdermal Drug Delivery Systems Market Size Market Share by Region in 2021

Figure 26. APAC Transdermal Drug Delivery Systems Market Size Market Share by Application in 2021

Figure 27. China Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Transdermal Drug Delivery Systems Market Size Market Share by Country in 2021

Figure 34. Europe Transdermal Drug Delivery Systems Market Size Market Share by Type in 2021

Figure 35. Europe Transdermal Drug Delivery Systems Market Size Market Share by Application in 2021

Figure 36. Germany Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Transdermal Drug Delivery Systems Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Transdermal Drug Delivery Systems Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Transdermal Drug Delivery Systems Market Size Market Share by Application in 2021

Figure 44. Egypt Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Transdermal Drug Delivery Systems Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 50. APAC Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 51. Europe Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 53. United States Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 54. Canada Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 57. China Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 58. Japan Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 59. Korea Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 61. India Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 62. Australia Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 63. Germany Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 64. France Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 65. UK Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 66. Italy Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 67. Russia Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 68. Spain Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 71. Israel Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Transdermal Drug Delivery Systems Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390